Validation of Random Forest Machine Learning Models to Predict Dementia-Related Neuropsychiatric Symptoms in Real-World Data
Journal of Alzheimer s Disease2020Vol. 77(2), pp. 855–864
Citations Over TimeTop 10% of 2020 papers
Javier Mar, Ania Gorostiza, Oliver Ibarrondo, Carlos Cernuda, Arantzazu Arrospide, Álvaro Iruín, Igor Larrañaga, Mikel Tainta, Enaitz Ezpeleta, Ane Alberdi
Abstract
Given their relatively good performance, the predictive models can be used to estimate prevalence of NPS in population databases.
Related Papers
- A Comparative Study Between Quetiapine and Risperidone in the Treatment of Schizophrenia(2005)
- A comparative study between Quetiapine and Risperidone in the treatment of first-episode schizophrenia(2008)
- A comparative study of quetiapine and risperidone for behavioral and psychological symptoms of Alzheimer's disease(2010)
- Comparison of behavioral and psychological symptoms between quetiapine and risperidone for treating vascular dementia(2013)
- Control Study between Quetiapine and Risperidone in the Treatment of Schizophrenia at Three Monnths(2011)